Ingen Technologies Inc (IGNT.PK) (PINK:IGNT)
From Ingen website:
Ingen Technologies is a leading provider of medical products that have been designed to advance traditional medical technologies for new applications and benefits for Medical Professionals, Patients and Insurance Payors.
The Company received ISO Certification in 2010 and has recently launched the Ingen Pulse Oximeter. In 2009, the Company added a new dimension to the respiratory healthcare market with the introduction of its new SMART Nasal Cannula Product Line, featuring exclusive Oxyview technology. The Oxyview is a patented in-line pneumatic oxygen flow meter, and since its entry into the respiratory market in late 2007 Ingen has grown to become the largest manufacturer of gravity-independent in-line oxygen flow meters.
All products are manufactured in California and available to the hospital, long term care, and home healthcare markets, with a focus on helping patients while also preventing unnecessary costs to the healthcare system. With approximately 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide, the overall respiratory market is worth an estimated $4 Billion in the U.S., and $8 billion globally.
Additional applications and markets include aviation, automotive, and government sources.
Current pps: 0.0002
A/S: Increased from 3.5B to 8B
O/S: 3.5B
Float: 3.5B
Link to google finance
Company website
News July/22 - Link
All News
>> Subscribe to our posts.
Monday, August 2, 2010
Subscribe to:
Post Comments (Atom)
IGNT doing reverse split. be careful.
ReplyDeleteI haven't see that in any of their filings yet. You have a link?
ReplyDeleteIGNT on reverse split link
ReplyDelete